Rapport Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RAPP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Jul 24	BuyUS$1,079,575	Synergy Capital Limited	Company	44,032	US$26.06
10 Jun 24	BuyUS$8,316,910	Sofinnova Investment, Inc.	Company	489,230	US$17.00
10 Jun 24	BuyUS$1,183,098	Synergy Capital Limited	Company	69,594	US$17.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAPP?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,479,420	6.14%
Hedge Funds	2,940,921	7.28%
VC/PE Firms	16,326,834	40.4%
Institutions	18,633,324	46.1%

Dilution of Shares: RAPP only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 107.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
22.2%	Third Rock Ventures, LLC	8,104,451	US$146.4m	0%	30.79%
15%	FMR LLC	5,486,468	US$99.1m	10.1%	0.01%
10.2%	Arch Venture Partners, L.P.	3,728,738	US$67.4m	0%	6.9%
8.04%	Cormorant Asset Management, LP	2,940,921	US$53.1m	0.02%	2.9%
7.59%	T. Rowe Price Group, Inc.	2,774,519	US$50.1m	-4.19%	no data
7.12%	Capital Research and Management Company	2,602,529	US$47.0m	0%	no data
6.83%	Johnson & Johnson Innovation - JJDC, Inc.	2,498,051	US$45.1m	0%	11.52%
5.46%	Sofinnova Investment, Inc.	1,995,594	US$36.1m	2.26%	3.21%
3.41%	Goldman Sachs Group, Investment Banking and Securities Investments	1,247,171	US$22.5m	1,660%	0.01%
2.98%	AllianceBernstein L.P.	1,088,921	US$19.7m	-0.18%	0.01%
2.68%	Goldman Sachs Asset Management, L.P.	980,730	US$17.7m	0%	no data
2.16%	Abraham Ceesay	789,703	US$14.3m	0%	no data
2.05%	Perceptive Advisors LLC	748,183	US$13.5m	0%	0.32%
1.58%	BlackRock, Inc.	576,118	US$10.4m	0%	no data
1.39%	The Vanguard Group, Inc.	506,767	US$9.2m	624%	no data
1.33%	Citadel Advisors LLC	487,458	US$8.8m	-17.7%	0.01%
1.31%	Steven Paul	477,642	US$8.6m	0%	no data
1.31%	David Bredt	477,642	US$8.6m	0%	no data
1.05%	Artal Group S.A.	384,197	US$6.9m	9.77%	0.21%
0.8%	Swamy Yeleswaram	290,831	US$5.3m	0%	no data
0.64%	Broad Street Principal Investments, L.L.C.	233,735	US$4.2m	0%	2.67%
0.57%	Logos Global Management, L.P.	208,910	US$3.8m	0%	0.47%
0.55%	Geode Capital Management, LLC	201,748	US$3.6m	0%	no data
0.54%	Bradley Galer	197,426	US$3.6m	0%	no data
0.51%	Woodline Partners LP	186,560	US$3.4m	9.04%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 23:20
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rapport Therapeutics, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Salveen Richter	Goldman Sachs
Lin Tsai	Jefferies LLC
Justin Walsh	JonesTrading Institutional Services, LLC